Antimicrobial resistance in bronchiectasis and cystic fibrosis varied widely in a study spanning 11 centers on 3 continents.
Experts break down the GOLD 2026 COPD guidelines, highlighting updates to diagnosis criteria, Group E risk categories, and ...
Imperial College London’s Jadwiga A. Wedzicha, MD, discusses anti-alarmin trial results in COPD and where biologics may fit ...
An economic evaluation found nontargeted hepatitis C screening in emergency departments offered the greatest health benefit ...
Pooled data on 2698 patients tie rituximab maintenance after bendamustine-rituximab to better PFS and OS in mantle cell lymphoma.
University of Barcelona’s Àlvar Agustí discusses what is new in the 2027 GOLD report and why the traditional narrative of ...
More than 4 in 5 patients with hand eczema referred for patch testing at a Shanghai dermatology hospital reacted to at least ...
The Community Oncology Alliance said final 2027 Medicare payment rules address longstanding gaps between hospital and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results